Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials
Open Access
- 3 March 2016
- journal article
- review article
- Published by IOS Press in Journal of Neuromuscular Diseases
- Vol. 3 (1), 1-28
- https://doi.org/10.3233/JND-160145
Abstract
Recent years have seen tremendous progress towards therapy of many previously incurable neuromuscular diseases. This new context has acted as a driving force for the development of novel non-invasive outcome measures. These can be organized in threeKeywords
This publication has 157 references indexed in Scilit:
- The 6‐minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter studyMuscle & Nerve, 2013
- ISMRM workshop on fat–water separation: Insights, applications and progress in MRIMagnetic Resonance in Medicine, 2012
- Characterization of the regional distribution of skeletal muscle adipose tissue in type 2 diabetes using chemical shift‐based water/fat separationJournal of Magnetic Resonance Imaging, 2011
- Changes in muscle T2 and tissue damage after downhill running in mdx MiceMuscle & Nerve, 2011
- Evaluation of muscles affected by myositis using magnetic resonance elastographyMuscle & Nerve, 2011
- Quantitative magnetization transfer in in vivo healthy human skeletal muscle at 3 TMagnetic Resonance in Medicine, 2010
- What are biomarkers?Current Opinion in HIV and AIDS, 2010
- k‐space water‐fat decomposition with T2* estimation and multifrequency fat spectrum modeling for ultrashort echo time imagingJournal of Magnetic Resonance Imaging, 2010
- Repeatability of DTI‐based skeletal muscle fiber trackingNMR in Biomedicine, 2010
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007